Vibliome Therapeutics
Keith Flaherty is on the Board of Advisors at Vibliome Therapeutics.
This person is not in the org chart
This person is not in any offices
Vibliome Therapeutics
Vibliome Therapeutics, LLC, has developed a novel systematic approach that enables the design of small molecule kinase inhibitors with unique selectivity profiles and extraordinary selectivity.